In the evolving landscape of diabetes management, novel medications like semaglutide and retatrutide are gaining traction. These agents, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family, offer https://kaitlynwnlt452967.wikinewspaper.com/user